Current medical treatment of estrogen receptor-positive breast cancer

World Journal of Biological Chemistry
Franco LumachiStefano Mm Basso

Abstract

Approximately 80% of breast cancers (BC) are estrogen receptor (ER)-positive and thus endocrine therapy (ET) should be considered complementary to surgery in the majority of patients. The advantages of oophorectomy, adrenalectomy and hypophysectomy in women with advanced BC have been demonstrated many years ago, and currently ET consist of (1) ovarian function suppression (OFS), usually obtained using gonadotropin-releasing hormone agonists (GnRHa); (2) selective estrogen receptor modulators or down-regulators (SERMs or SERDs); and (3) aromatase inhibitors (AIs), or a combination of two or more drugs. For patients aged less than 50 years and ER+ BC, there is no conclusive evidence that the combination of OFS and SERMs (i.e., tamoxifen) or chemotherapy is superior to OFS alone. Tamoxifen users exhibit a reduced risk of BC, both invasive and in situ, especially during the first 5 years of therapy, and extending the treatment to 10 years further reduced the risk of recurrences. SERDs (i.e., fulvestrant) are especially useful in the neoadjuvant treatment of advanced BC, alone or in combination with either cytotoxic agents or AIs. There are two types of AIs: type I are permanent steroidal inhibitors of aromatase, while type II are r...Continue Reading

References

Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C K OsborneS A Fuqua
Oct 3, 2002·Journal of the National Cancer Institute·Richard R Love, John Philips
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T TominagaY Ohashi
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C RoseR Lang
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·W R Miller
Apr 28, 2004·Breast Cancer Research and Treatment·Michael D JohnsonTodd C Skaar
Aug 4, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J S Tobias, A Howell
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy E DavidsonMartin D Abeloff
Dec 3, 2005·Cancer Research·Cynthia X MaRichard M Weinshilboum
Sep 21, 2006·Journal of the National Cancer Institute·Davide MauriJohn P A Ioannidis
Jan 27, 2007·The Cochrane Database of Systematic Reviews·L J GibsonJ M Bliss
Feb 22, 2007·Journal of the National Cancer Institute·Trevor J PowlesMitch Dowsett
Aug 1, 2009·Nature Reviews. Drug Discovery·Pixu LiuJean J Zhao
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Shom GoelJane Beith
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettRichard Peto
Apr 21, 2010·Cancer Prevention Research·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Elizabeth H HammondAntonio C Wolff
Dec 15, 2010·Current Medicinal Chemistry·F LumachiV Camozzi
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georg PfeilerMichael Gnant
Oct 20, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S AebiUNKNOWN ESMO Guidelines Working Group
Mar 8, 2012·Journal of the National Cancer Institute·James M RaeUNKNOWN ATAC trialists
Mar 13, 2012·Molecular Oncology·Shannon PuhallaNancy E Davidson
Aug 3, 2012·The New England Journal of Medicine·Rita S MehtaGabriel N Hortobagyi
Jan 3, 2013·Current Medicinal Chemistry·F LumachiS M M Basso
Jan 21, 2014·Clinical Breast Cancer·Charles L VogelDeborah Braccia
May 27, 2014·American Society of Clinical Oncology Educational Book·Victor G Vogel
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinJennifer J Griggs
Jun 3, 2014·The New England Journal of Medicine·Olivia PaganiUNKNOWN International Breast Cancer Study Group

❮ Previous
Next ❯

Citations

Mar 2, 2016·Theoretical Biology & Medical Modelling·Nicolas CarelsJack Adam Tuszynski
Apr 10, 2016·British Journal of Clinical Pharmacology·Linda S SteelmanJames A McCubrey
Jan 3, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Khosrow-KhavarL Azoulay
Mar 28, 2018·Reproduction : the Official Journal of the Society for the Study of Fertility·Benjamin Fisch, Ronit Abir
Aug 2, 2017·The Pharmacogenomics Journal·G S HwangM V Trivedi
Nov 7, 2019·Journal of Cellular Biochemistry·Wen-Jing LiuSheng-Xiang Lin
Apr 28, 2020·American Journal of Epidemiology·Farzin Khosrow-KhavarLaurent Azoulay
May 8, 2016·Clinical Science·Margaret A ZimmermanSarah H Lindsey
Nov 29, 2016·Journal of Gynecologic Oncology·Hoon KimYoung Min Choi
Apr 30, 2017·Oncology Letters·Carlos Martínez-CampaSamuel Cos
Apr 19, 2019·Antioxidants·Meenakshi SudhakaranAndrea I Doseff
Jun 4, 2019·Journal of Biochemical and Molecular Toxicology·Ren GuanghuiQiu Guobin
Sep 24, 2020·International Journal of Molecular Sciences·Carmen Ortiz-SánchezJaime Matta
Dec 28, 2016·Journal of Cancer Research and Clinical Oncology·Xi ZhangSophie Doisneau-Sixou
Oct 23, 2020·Molecular Cancer Therapeutics·Sundee DeesIqbal S Grewal
Dec 18, 2020·Frontiers in Endocrinology·Milad RouhimoghadamEdward J Filardo
Oct 9, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ozge SaatciOzgur Sahin
Oct 26, 2021·Expert Opinion on Investigational Drugs·Ya-Chi ChenXiaojing Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved